Moderna With 94.1% Efficacy Gets Emergency Use Authorisation By WHO
Becoming the fifth vaccine in the list, Moderna's COVID-19 vaccine has secured emergency use authorisation by the World Health Organisation. Approved in the US on December 18, 2020, the vaccine has 94.1% efficacy, as analysed by the WHO's Strategic Advisory Group of Experts. The listing is an official process to make the vaccine available for all. Four other vaccines are Pfizer BioNTech, AstraZeneca, Serum Institute of India's Covishield, and Janssen.